TSHA in the 13F filings
Taysha Gene Therapies Inc · CUSIP 877619106
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 1 listed it in both
- Shares listed
- 27,585,203
- combined, among listed positions
- Reported value
- $124m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 16 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -3,477,894.
Managers listing TSHA in Q1 2026
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 14,321,255 shares now+792,889
- D. E. Shaw & Co.existing position · 4,427,301 shares now+413,666
- Two Sigma Investments LPexisting position · 742,081 shares now+390,955
- Moore Capital Management LPnew position · 328,831 shares now+328,831
- Renaissance Technologies LLCexisting position · 413,203 shares now+242,103
Reductions
- Point72 Asset Management LPexisting position · 461,856 shares now-3,406,826
- Citadel Advisors LLCexisting position · 411,135 shares now-1,443,720
- Invesco Ltdexisting position · 368,021 shares now-964,759
- Wellington Management Group LLPexisting position · 626,361 shares now-84,874
- Squarepoint Ops LLCexisting position · 410,282 shares now-61,295
New positions and exits
New (5)
Exited (2)
- Jane Street Group LLCwas $897k
- Voloridge Investment Management LLCwas $301k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2020 | 1 | $11m | n.a. | n.a. |
| Q4 2020 | 1 | $13m | n.a. | n.a. |
| Q1 2021 | 1 | $10m | n.a. | n.a. |
| Q2 2021 | 1 | $11m | n.a. | n.a. |
| Q3 2021 | 1 | $9.3m | n.a. | n.a. |
| Q4 2021 | 1 | $5.8m | n.a. | n.a. |
| Q1 2022 | 1 | $3.3m | n.a. | n.a. |
| Q2 2022 | 1 | $1.9m | n.a. | n.a. |
| Q3 2022 | 1 | $965k | n.a. | n.a. |
| Q4 2022 | 1 | $3.4m | n.a. | n.a. |
| Q1 2023 | 1 | $1.2m | n.a. | n.a. |
| Q2 2023 | 1 | $992k | n.a. | n.a. |
| Q3 2023 | 1 | $4.7m | n.a. | n.a. |
| Q4 2023 | 1 | $6.5m | 1 | 0 |
| Q1 2024 | 2 | $11m | 1 | 0 |
| Q2 2024 | 2 | $11m | 1 | 0 |
| Q3 2024 | 2 | $9.5m | 1 | 0 |
| Q4 2024 | 1 | $6.4m | 0 | 0 |
| Q1 2025 | 1 | $5.1m | 0 | 0 |
| Q2 2025 | 1 | $9.5m | 1 | 0 |
| Q3 2025 | 2 | $36m | 1 | 1 |
| Q4 2025 | 1 | $861k | 15 | 6 |
| Q1 2026 | 2 | $2.9m | 16 | 8 |
| Q2 2026 | 4 | $25m | 12 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TSHA and GILD →TSHA and AMGN →TSHA and ARGX →Choose a stock to compare with TSHA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TSHA, latest filings →Back to the 13F Explorer →